Stay updated on Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Sign up to get notified when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The DREAMM-3 clinical trial record is displayed, describing a Phase 3 comparison of belantamab mafodotin with pomalidomide plus dexamethasone for relapsed or refractory multiple myeloma. The record includes trial outcomes, participation criteria, locations, and supporting documents.
    Difference
    100%
    Check dated 2026-11-10T21:26:50.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T22:02:10.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A banner was added announcing NIH’s transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision label changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:21:48.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.3%
    Check dated 2026-10-06T22:25:15.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, blocking access to the study record. Linked documents and related content appear removed or unavailable on this page.
    Difference
    18%
    Check dated 2026-09-23T00:17:20.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    A new revision tag Revision: v3.7.0 was added to the page. The changes also removed several related-topic items (Multiple myeloma, related topics:, MedlinePlus Genetics) and the older Revision: v3.6.6.
    Difference
    0.1%
    Check dated 2026-09-15T23:40:46.000Z thumbnail image

Stay in the know with updates to Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.